Upgrading and expansion of HCG API manufacturing completed
Aspen Oss has completed a major upgrading and expansion project at its hCG manufacturing facility in Boxtel, the Netherlands; an extensive project that was started in 2017.
Aspen Oss has completed a major upgrading and expansion project at its hCG manufacturing facility in Boxtel, the Netherlands; an extensive project that was started in 2017.
Through its collection program “Mothers for Mothers”, urine
from pregnant Dutch women is collected on a weekly basis. From the urine we
extract the API human Chorionic Gonadotrophin (hCG), which is used for
fertility treatments.
While hCG was previously produced at two different sites of Aspen
Oss, the upgrading of the Boxtel facility has made it possible that the entire
production process, from urine to API, can now be performed under one roof, in
a dedicated hCG facility.
Aspen Oss, in order to comply with the highest standards for
product safety, added a virus filtration step in the production process of hCG.
and successfully validated the new process.
If you want to learn more on how our hCG capabilities can
add value to your product, please contact us at [email protected]
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance